loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

Jupiter Life Line Hospitals Results: Latest Quarterly Results & Analysis

Open Free Trading Account Online with ICICIDIRECT
+91
Jupiter Life Line Hospitals Ltd. 30 Jan 2026 17:38 PM

Q3FY26 Quarterly Result Announced for Jupiter Life Line Hospitals Ltd.

Healthcare Facilities company Jupiter Life Line Hospitals announced Q3FY26 results

  • Revenue: Rs 366.5 crore against Rs 332.9 crore during Q3FY25, change 10%.
  • EBITDA: Rs 83.4 crore against Rs 76.4 crore during Q3FY25, change 9%.
  • PBT: Rs 56.9 crore against Rs 66.8 crore during Q3FY25, change -15%.
  • PAT: Rs 42.5 crore against Rs 52.3 crore during Q3FY25, change -19%.

Ankit Thakker JMD & CEO, said: “We are pleased to announce the successful completion of our new hospital in Dombivli, having received all major requisite licenses. The project was delivered ahead of the planned Q1FY27 schedule, with the entire civil construction, fit-out, and biomedical installation completed in just over 24 months.

In this first phase, we have built the infrastructure for the full 500-bed capacity and completed fit-outs for over 300 beds at a capex of approximately Rs 425 crore. We will initially begin operations with 200 beds and scale up in a phased manner as occupancy increases.

OPD services are scheduled to begin gradually next week. The hospital will be formally inaugurated on February 15, 2026, following which it will commence full clinical operations, including emergency services, critical care, and surgeries.”

Result PDF

Healthcare Facilities company Jupiter Life Line Hospitals announced H1FY25 results

  • Total Income Rs 612.8 crore with growth 20.5 % YoY.
  • EBITDA Rs 141.9 crore with growth 22.3 % YoY.
  • PAT Rs 96.1 crore with growth 9.6 % YoY.

Ankit Thakker ED & CEO, Jupiter Life Line Hospitals, said: “We are pleased to report a 20.5% increase in total income, reaching Rs 612.8 crore in H1FY25, up from Rs 508.4 crore in H1FY24. EBITDA rose by 22.3% to Rs 141.9 crore, compared to Rs 116.1 crore in H1FY24, while PAT grew by 9.6% to Rs 96.1 crore in H1FY25, up from Rs 87.7 crore in H1FY24. This growth has been driven by strong operational performance across all three hospitals, reflected in higher occupancy rates and increased ARPOB.

In Q2FY25, we added 22 beds at our Pune hospital and are in the process of adding 75 new beds at our Indore hospital, which is expected to be operational by Q4FY25.

We are focused on expanding the Jupiter brand, enhancing management professionalism, and increasing our footprint. With this regards, the construction of our Dombivli hospital is progressing on schedule. For our Pune hospitals, we are in the advanced stages of obtaining the necessary regulatory approvals. With the addition of these two new facilities, our total bed capacity will increase to ~2,200 beds, and we are currently identifying another location to raise our total capacity to ~2,500 beds.

We have effectively leveraged our core strengths to drive growth, solidifying our position as a leading healthcare provider in Western India. By aligning these initiatives with our long-term growth vision, we have established a strong foundation for sustainable expansion and improved patient care.”

Result PDF

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Download App

Download Our App

Get it on google Play Store Download on the App Store
market app